FDA details risk-based cellular therapy and regenerative medicine guidelines

regenerative medicine

The FDA has issued two final guidances and two draft guidances, all designed to articulate the agency’s approach to developing and overseeing novel cellular therapies and other regenerative medicine products.

The agency said its suite of four guidance documents constituted a risk-based and science-based policy framework approach designed to support innovative product development while clarifying the FDA’s authority, its enforcement priorities against products deemed to raise potential significant safety concerns.

The two final guidances are designed to clarify the FDA’s interpretation of the risk-based criteria manufacturers must use to determine whether a product is subject to the FDA’s premarket review.

…

“This field is dynamic and complex. As such, it has presented unique challenges to researchers, healthcare providers, and the FDA as we seek to provide a clear pathway for those developing new therapies in this promising field, while making sure that the FDA meets its obligation to ensure the safety and efficacy of the medical products that patients rely upon,” FDA Commissioner Scott Gottlieb, M.D., said in a statement.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: FDA issues final and draft regenerative medicine guidance documents

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-11-17-at-12.18.09-PM
Challenging glyphosate fear-mongering: Statewide Nebraska study finds no link between weedkiller use and non-Hodgkin lymphoma
BEMT Lotion for Freckled Skin
Burned by FDA bureaucracy: Why Americans waited decades for cancer-preventing sunscreen
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-11-17-at-12.56.22-PM
RFK Jr.’s CDC blocked measles risk alert for pregnant women; 112 contracted the disease, and one-quarter were hospitalized
Crisp Physicians’ Protest Sign Close-Up
‘He’s a disgrace’: Some newly-elected legislators and health groups call for RFK Jr. impeachment 
Nicotine Products on Gray Marble
Comparing vaping, nicotine patches and cigarettes: Not ‘safe vs. dangerous’  but ‘less harmful vs. more harmful’
ChatGPT-Image-Aug-18-2026-12_22_33-PM-2
‘The cure for measles is chicken soup and vitamin A’: Kennedy’s dangerous history of mocking vaccines
Split-Toned-Capitol-Healthcare-Rally
Viewpoint: Here’s how Congress can begin to reverse a two-year public health disinformation slide
Screenshot-2026-11-13-at-10.02.02-AM
Viewpoint: Why it’s such a big deal that under Trump-RFK Jr., the U.S. has lost its ‘measles-free’ status  
Screenshot-2026-11-17-at-11.04.14-AM
There are more than 6,000 genetic disorders. For the first time, gene editing is making some treatable. Are we ready?
Screenshot-2026-11-16-at-1.18.40-PM
‘Measles fiasco one of many healthcare failures’: Republican Sen. Bill Cassidy says it's time to fire RFK Jr.
Man in Green “Make America Healthy Again” Cap
Viewpoint: MAHA 2.0? Will the wellness grifters rescue RFK Jr.?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.